About
Mika Nishimura has served on Accuray's Board since August 2021 and chairs the Nominating and Corporate Governance Committee. Since 2011 she has been an Operational Partner with Gilde Healthcare Partners, and she previously served as Vice President of Commercialization at nVision Medical (acquired by Boston Scientific) and Vice President, Commercial Development at Auxogyn. She serves on the boards of SI-BONE, HOYA Corp and NEC Corporation and advises Tristel plc. She holds an MBA from Harvard Business School and a B.A. in Economics from Yale University.
Roles
Accuray Inc.
Director (Chair, Nominating and Corporate Governance Committee) · Current role
August 2021–present
Gilde Healthcare Partners
Operational Partner
2011 - present
nVision Medical Corporation
Vice President of Commercialization
2015 - 2020
Auxogyn, Inc.
Vice President, Commercial Development
—
ev3 Inc.
Vice President of International Sales Operations and Marketing
—
External Roles
SI-BONE, Inc.
Director
2021 - present
HOYA Corp
Director
2022 - present
NEC Corporation
Director
2025 - present
Tristel, plc
Board advisor
2021 - present
Director Compensation
FY 2025Fees earned or paid in cash
$62,500
ComponentAnnual cash retainer plus committee retainers earned in fiscal 2025
Stock awards
$126,225
ComponentAnnual RSU grant (11/29/24), ASC 718 grant-date fair value
Total
$188,725
Also at Accuray Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.